CIK 0001228627
- Non-accelerated filer
- Smaller reporting company
Opus Genetics, Inc.
Sign in to watch- Ticker
- IRD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 113516358
- Phone
- +1 984-884-6030
- Business address
- 8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
- Former names
- Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,211,769
- in 7 filings, $50K under 10b5-1 plans
Net −$3,211,769. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Foundation Fighting Blindness Retinal Degeneration Fund −$2.8M Director sold 15% of stake
- Gagnon Robert E. −$177K Chief Financial Officer sold 7% of stake
- Magrath George −$145K Chief Executive Officer sold 2% of stake
- YERXA BENJAMIN R −$117K President sold 5% of stake
- SCHACHLE JOSEPH K −$17K Chief Operating Officer sold 2% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-23 | Jayagopal Ashwath Chief Scientific & Dev. Ofc. | Sale | −7,542 | $5.19 | $39K | 509,233 |
| 2026-03-16 | Jayagopal Ashwath Chief Scientific & Dev. Ofc. | Sale | −3,719 | $5.12 | $19K | 516,775 |
| 2026-02-12 | Jayagopal Ashwath Chief Scientific & Dev. Ofc. | Shares withheld for taxes | −5,313 | $3.39 | $18K | 520,494 |
| 2026-01-22 | Jayagopal Ashwath Chief Scientific & Dev. Ofc. | Grant or award | +400,000 | 525,807 | ||
| 2025-03-13 | Jayagopal Ashwath Chief Scientific & Dev. Ofc. | Grant or award | +52,500 | 125,807 | ||
| 2025-03-13 | Jayagopal Ashwath Chief Scientific & Dev. Ofc. | Grant or award · Employee Stock Option (right to buy) | +52,500 | 52,500 | ||
| 2025-02-13 | Jayagopal Ashwath Chief Scientific & Dev. Ofc. | Shares withheld for taxes | −5,193 | $1.15 | $6K | 73,307 |
| 2024-05-22 | Jayagopal Ashwath Chief Scientific & Dev. Ofc. | Purchase | +3,500 | $1.77 | $6K | 78,500 |
| 2024-02-12 | Jayagopal Ashwath Chief Scientific & Dev. Ofc. | Grant or award | +75,000 | 75,000 | ||
| 2024-02-12 | Jayagopal Ashwath Chief Scientific & Dev. Ofc. | Grant or award · Employee Stock Option (right to buy) | +225,000 | 225,000 |
Page 1 of 1 · 10 trades